References
  1. Lui K, Lee SK, Kusuda S, Adams M, Vento M, Reichman B, Darlow BA, Lehtonen L, Modi N, Norman M, et al. Trends in outcomes for neonates born very preterm and very low birth weight in 11 high-income countries. J Pediatr, 215 (2019), pp. 32-40.e14
  2. Wu KY, Jensen EA, White AM, Wang Y, Biko DM, Nilan K, Fraga MV, Mercer-Rosa L, Zhang H, Kirpalani H. Characterization of disease phenotype in very preterm infants with severe bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2020;201(11):1398-1406.
  3. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163(7):1723-1729.
  4. Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman S, Blackmon L, Jobe A. Summary Proceedings from the bronchopulmonary dysplasia group. Pediatrics 2006;117(3 Pt 2):S52-S56.
  5. Shepherd EG, Clouse BJ, Hasenstab KA, Sitaram S, Malleske DT, Nelin LD, Jabcherla SR. Infant pulmonary function testing and phenotypes in severe bronchopulmonary dysplasia. Pediatrics 2018;141(5):e20173350 [epub ahead of print]
  6. Smyth JA, Tabachnik E, Duncan WJ, Reilly BJ, Levison H. Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics 1981;68(3):336-340.
  7. Clark RH, Bloom BT, Spitzer AB, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatric 2006; 117(6):1979-1987.
  8. Allen J, Zwerdling R, Ehrenkranz R, Gaultier C, Geggel R, Greenough A, Kleinman R, Klijanowicz A, Martinez F, Ozdemir A, Et al. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003; 168(3):356-396.
  9. Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR. Inhaled bronchodilator use for infants with bronchopulmonary dysplasia. J Perinatology 2015;35:61-66.
  10. Guaman MC, Gien J, Baker CD, Zhang H, Austin ED, Collaco JM. Point prevalence, clinical characteristics, and treatment variation for infants with severe bronchopulmonary dysplasia. Am J Perinatol 2015;32(10):960-967.
  11. Bamat NA, Kirpalani H, Feudtner C, Jensen EA, Laughon MM, Zhang H, Monk HM, Passarella M, Lorch SA. Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children’s Hospitals. J Perinatol 2019;39(9):1291-1299.
  12. Ng Gy, da Silca O, Ohlsson A. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2012; 6.
  13. Fayon M, Tayara N, Germain C, Choukroum ML, De La Roque ED, Chêne G, Breilh D, Marthan R, Demarquez JL. Efficacy and tolerance of high-dose inhaled ipratropium bromide vs terbutaline in intubated premature human neonates. Neonatology 2007;91:167-173.
  14. Lee H, Arnon S, Silverman M. Bronchodilator aerosol administered by metered dose inhaler and spacer in subacute neonatal respiratory distress syndrome. Arch Dis in Childhood 1994;70:218-22.
  15. Pfenninge J, Aebi C. Respiratory response to salbutamol (albuterol) in ventilator-dependent infants with chronic lung disease: pressurised aerosol delivery versus intravenous injection. Intensive Care Medicine 1993;19:251-5.
  16. Rotschild A, Solimano A, Puterman M, Smyth J, Sharma A, Albersheim S. Increased compliance in response to salbutamol in premature infants with developing bronchopulmonary dysplasia. J Pediatrics 1989;115:984-91.
  17. Sivakumar D, Bosque E, Goldman SL. Bronchodilator delivered by metered dose inhaler and spacer improves respiratory system compliance more than nebulizer-delivered bronchodilator in ventilated premature infants. Pediatr Pulm 1999;27:208-12.
  18. Wilkie RA, Bryan MH. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J Pediatrics 1987;111:278-83.
  19. Morrow Dk, Schilling D, McEvoy CT. Response to bronchodilators in very preterm infants with evolving bronchopulmonary dysplasia. Res Rep Neonatol 2015; 5:113-117.
  20. Levin DL, Garg A, Hall LJ, Slogic S, Jarvis JD, Leiter JC. A prospective randomized controlled blinded study of three bronchodilators in infants with respiratory syncytial virus bronchiolitis on mechanical ventilation. Pediatr Crit Care Med 2008;9:598-604.
  21. Carrol CL, Sala K, Zucker AR, Schramm CM. Pulmonary mechanics following albuterol therapy I mechanically ventilated infants with bronchiolitis. J Asthma 2012;49(7):688-296.
  22. Schramm CM, Sala KA, Carroll CL. Clinical examination does not predict response to albuterol in ventilated infants with bronchiolitis. Pediatr Crit Care Med 2017;18(1):e18-e23.
  23. Khan SY, O’Driscoll BR. Is nebulized saline a placebo in COPD?BMC Pulm Med . 2004;4:9.
  24. House SA, Gadomski AM, Ralston SL. Evaluating the placebo status of nebulized normal saline in patients with acute viral bronchiolitis: A systematic review and meta-analysis. JAMA Pediatr 2020;174(3):250-259.
  25. Van der Schans CP. Bronchial mucus transport. Resp Care 2007;52(9):1150-1158.
  26. Rogers DF. Mucoactive agents for airway mucus hypersecretory diseases. Resp Care 2007;52(9):1176-1193.
  27. Schuepp KG, Straub D, Moller A, Wildhaber JH. Deposition of aerosols in infants and children. Journal of Aerosol Medicine 2004;17(2):153-156.
  28. Amirav I, Newhouse MT. Deposition of small particles in the developing lung. Pediatric Respiratory Reviews 2012;13:73-78.
  29. Fink JB. Aerosol delivery to ventilated infants and pediatric patients. Respiratory Care 2004;49(6):653-665.
  30. Dubus JC, Vecellio L, de Monte M, Fink JB, Grimbert D, Montharu J, Valat C, Behan N, Diot P. Aerosol deposition in neonatal ventilation. Pediatric Res 2005;58(1):10-4.
  31. Berlinski A, Willis JR. Effect of tidal volume and nebulizer type and position on albuterol delivery in a pediatric model of mechanical ventilation. Respiratory Care 2015;60(10):1424-1430.
  32. Johnston DA, Gilmore TW, Gosselin KP. A comparison of metered-dose inhaled albuterol vs endotracheal liquid bolus albuterol for treatment of bronchoconstriction. Resp Care 2015; 60(5)627-635.
  33. ElHansy MHE, Boules ME, El Essawy AFM, Al-Kholy MB, Abdelrahman MM, Said ASA, Hussein RRS, Abdelrahim ME. Inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during invasive mechanical ventilation. Pulm Pharmacol Ther 2017;45:159-163.